Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 17, 2009

National Jewish Health Accesses InterMune’s Idiopathic Pulmonary Fibrosis DNA Database

  • InterMune will collaborate with National Jewish Health investigators to help further the research of inherited genetic factors that may play a role in idiopathic pulmonary fibrosis (IPF).

    InterMune will provide researchers at National Jewish Health with access to DNA collected from patients who participated in the company’s Phase III trials in IPF for both pirfenidone and actimmune (interferon gamma-1b). The database includes DNA from approximately 1,500 IPF patients.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »